Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus.
about
Disturbances of apoptotic cell clearance in systemic lupus erythematosusAnaemia in systemic lupus erythematosus: from pathophysiology to clinical assessmentUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaGene expression in systemic lupus erythematosus: Bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signaturesAutologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Suspects in the tale of lupus-associated thrombocytopenia.Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.Bone marrow stem cells and stromal cells in autoimmune cytopenias.Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.Autologous stem cell transplantation for systemic lupus erythematosus.In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus.Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosusReduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus.Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis.Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.Monocyte and macrophage abnormalities in systemic lupus erythematosus.Autologous hematopoietic stem cell transplantation in autoimmune diseases.The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.Mesenchymal stem cells transplantation for systemic lupus erythematosus.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation.Stemness Characteristics of Periodontal Ligament Stem Cells from Donors and Multiple Sclerosis Patients: A Comparative Study.Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia
P2860
Q21195358-23CCDD2D-95BB-47AE-B501-9B62B7773EBFQ24675466-6A1BC8F2-00E5-41D8-8D11-51316DA5DFEFQ26777402-B8BDF81D-85EA-449B-A026-6EDD9D28A656Q27490156-92460BFF-8AEA-4D68-AA7B-FE50D4C0EBB5Q30582614-E44F404F-5156-4A4C-9328-2F98B1ED2126Q33371650-F81DEB20-0F4E-4F58-B2E8-ED9D4346C890Q33821471-7FDB066E-08B6-43EA-87B9-F65ABDDFA793Q34120467-6B3FEC9F-44EC-4B65-879B-A5F62E1277F4Q34245461-BDFB0C0C-BFD0-48FD-BD67-9029E8FE8503Q34769871-1B484602-F75A-4E93-9CE7-A2AE25F52238Q35152132-972F86E7-07B7-49AF-8F14-C2529E2C658AQ35824509-BB346053-A907-47A7-B3CD-960ED01195B8Q35953561-BA2FEA92-4D30-4E14-ABF4-F640DC221F3AQ35954549-7F65F9EA-8988-4BF8-AE50-455D8424CB04Q36059617-5AF40FCD-22FA-4775-9F8B-C48D0042727EQ36206615-69147688-D2E0-47B7-AE24-743E50D7ACB5Q36392411-6B70983C-D175-47C4-818C-CC37F14A8EB9Q37257125-586820C5-E6E5-4574-A615-53009877C87AQ37535318-E8D7665F-4B99-44EF-8484-9775CF10B5DCQ37719559-100359FD-222C-4FED-ADFB-51F6A17292DAQ37777065-50060C5E-ED1D-4E46-A393-2034C8C5C77EQ37810087-EDCD7BB5-B851-4496-A17B-945212C31887Q37947986-56D48E39-7F44-4943-A1F3-47C644AE7933Q38328472-7B19C029-9598-462B-9C7F-AA4BD0AD65E2Q38840236-0878A96A-CFA6-4136-9C08-1E6B014F9EE2Q46662797-38689B70-1560-4561-8016-9ECB0EB3785BQ48130044-E08C6243-7E1A-47A3-A645-55BF4573CA8AQ58041641-595FAFC0-D0C5-4959-8DE9-3100382A493C
P2860
Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Increased apoptosis of bone marrow CD34
@nl
Increased apoptosis of bone ma ...... systemic lupus erythematosus.
@en
type
label
Increased apoptosis of bone marrow CD34
@nl
Increased apoptosis of bone ma ...... systemic lupus erythematosus.
@en
prefLabel
Increased apoptosis of bone marrow CD34
@nl
Increased apoptosis of bone ma ...... systemic lupus erythematosus.
@en
P2093
P2860
P1476
Increased apoptosis of bone ma ...... systemic lupus erythematosus.
@en
P2093
Boumpas DT
Eliopoulos GD
Gordon-Smith EC
Papadaki HA
P2860
P304
P356
10.1046/J.1365-2141.2001.03076.X
P407
P577
2001-10-01T00:00:00Z